Hepatitis C in children with chronic kidney disease: A single-center, Egypt

Doaa Mohammed Youssef1, Hanaa Abdo1, Ahmed Alakhras1

  • 1Department of Pediatrics, Zagazig University, Zagazig, Egypt.

Insights

Hepatitis C virus (HCV) infection affects 18% of children with chronic kidney disease (CKD). Longer CKD duration increases HCV risk, potentially worsening kidney function and lowering hemoglobin. Routine HCV screening in pediatric CKD patients is recommended.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Hepatology

Background:

  • Hepatitis C virus (HCV) prevalence varies globally, with Egypt reporting the highest rates.
  • Chronic kidney disease (CKD) affects children, increasing their susceptibility to comorbidities.
  • Understanding HCV prevalence in pediatric CKD is crucial for disease management.

Purpose of the Study:

  • To determine the incidence of hepatitis C virus (HCV) infection in children with chronic kidney disease (CKD).
  • To investigate the association between HCV infection and clinical/laboratory parameters in pediatric CKD patients.
  • To evaluate the impact of HCV infection on CKD progression and associated morbidities.

Main Methods:

  • A cross-sectional study involving 50 non-dialysis pediatric CKD patients.
  • Comprehensive clinical evaluation, including medical history and physical examination.
  • Laboratory assessments included hemoglobin, AST, ALT, urea, creatinine, and eGFR.
  • HCV antibody detection using third-generation enzyme immunoassay (EIA).

Main Results:

  • Hepatitis C virus (HCV) antibodies were detected in 18% (9 out of 50) of the pediatric CKD cohort.
  • HCV-positive children were older, had longer CKD duration, lower eGFR, lower hemoglobin, and higher ALT, urea, and creatinine levels.
  • HCV infection correlated with poorer renal function (lower eGFR) and increased hospital admission duration.

Conclusions:

  • 18% of children with chronic kidney disease (CKD) are infected with hepatitis C virus (HCV).
  • Longer duration of renal disease is a significant risk factor for HCV positivity in this population.
  • HCV infection in pediatric CKD may accelerate kidney function decline and negatively impact hemoglobin levels, necessitating routine screening.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...